CMPX
NASDAQ · Biotechnology
Compass Therapeutics Inc
$1.38
-0.44 (-24.18%)
Open$1.54
Previous Close$1.82
Day High$1.54
Day Low$1.15
52W High$6.88
52W Low$1.61
Volume—
Avg Volume2.70M
Market Cap330.46M
P/E Ratio—
EPS$-0.31
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+3,796.4% upside
Current
$1.38
$1.38
Target
$53.77
$53.77
$36.32
$53.77 avg
$66.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 182.11M | 191.80M |
| Net Income | -66,446,946 | -42,646,254 | -48,286,720 |
| Profit Margin | -5,808.8% | -23.4% | -25.2% |
| EBITDA | -75,469,235 | -49,107,977 | -55,425,546 |
| Free Cash Flow | — | -37,978,554 | -43,960,363 |
| Rev Growth | — | -8.0% | +10.9% |
| Debt/Equity | — | 0.29 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |